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Background
Mesenchymal stem cells (MSC) are adult stem cells pre-
sent in bone marrow (BM), fat and in many other tis-
sues. MSC have strong immunosuppressive qualities in
vitro. The immunosuppression seems to work both by
paracrine action and cell-cell contact. MSC inhibit NK-
cells, B-cells, dendritic cells, Th1-cells and activate regu-
latory T-cells. The presence of floating single MSC in
human synovial fluid (SF) is a normal phenomenon and
the number of MSC in SF is much lower in RA than in
osteoarthritis (OA). SF in RA might be impaired in
recruiting MSC to the joint and the proliferation poten-
tial of MSC in RA patients could be suppressed by the
synovitis or be exhausted as suggested by the decreased
telomere length. Administration of additional MSC
might therefore have great potential in the treatment of
inflammatory arthritis as we and others have shown in
different experimental arthritis models.
Aim
To evaluate the presence and number of MSC in SF of
JIA patients and to see if addition of healthy MSC was
capable of immunosuppression of the synovial T-cells in
JIA patients.
Methods
We used the criteria of the ISCT [Horwitz EM etal.
Cytotherapy. 2005;7(5):393-5.] to culture the MSC and
used CFSE staining for lymphocytes and our standard
setting for suppression with regulatory T-cells as
described [Vercoulen Y etal. Plos One 2009; 4(9)].
Results
In JIA patients we find around 5-10 x10
6 cells per milli-
liter SF with 1.2-2.4 x10
6 CD4+ cells and 1.6-3.2 x10
6
CD8+ cells per ml. In the SF of arthritic knees from 14
JIA patients we found mesenchymal stem cells at a low
rate: a median of 4 CFU-F (with a maximum of 81
CFU-F) per million SF cells [normal healthy SF contains
250 CFU-F per 1 million SF ce l l s ] .W ef o u n dt h a ta d d -
ing allogeneic healthy BM derived MSC to anti-CD3 sti-
mulated SF cells of JIA patients showed dose dependent
suppression of SF CD4+ and CD8+ T cell proliferation
(Fig 1).
Conclusion
A low number of CFU-F were found in the SF of JIA
patients. The addition of allogeneic MSC to SF of JIA
patients suppressed the synovial CD4+ and CD8+ T cell
proliferation. A ratio of 1 MSC per 5 CD4+ or 5 CD8+
cells already yielded good results.
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